Chubb Launches Global Transactional Risk Platform to Grow its Footprint Internationally
Get Alerts CB Hot Sheet
Join SI Premium – FREE
Appoints
Chubb's existing
"Chubb is positioned to support our broker partners and clients with transactional risk solutions in jurisdictions across the world with our new international business lead," said Markovich. "Josh's deep understanding of transactional risk underwriting, and leadership experience sourcing and leading M&A insurance placements will complement our goal to grow our transactional risk practice as a global platform."
Cowen will report to
About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. As an underwriting company, we assess, assume and manage risk with insight and discipline. We service and pay our claims fairly and promptly. The company is also defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb maintains executive offices in
Chubb®, Chubb logo® and Chubb. Insured.SM are trademarks of Chubb.
View original content to download multimedia:https://www.prnewswire.com/news-releases/chubb-launches-global-transactional-risk-platform-to-grow-its-footprint-internationally-302090994.html
SOURCE Chubb INA Holdings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK hynix Accelerates 40 Trillion won Share Repurchase and Cancellation Program, Pursues Shareholder Return Expansion to 'Over 50% of FCF'
- DomoAI Launches Seedance 2.5 and MiniMax H3 in Omni Reference for Long-Form Character Storytelling and Music Video Creation
- BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share